Assessing the association between single-nucleotide polymorphisms and toxicity in nivolumab-treated non-small cell lung cancer patients.
Latest Information Update: 02 May 2018
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacodynamics
- 02 May 2018 New trial record
- 26 Apr 2018 Results published in the British Journal of Cancer